Skip to main content
Log In
Alger
  • About Alger
    • Our History
      Our Investment Approach
      Investment Team
      Careers
      Commitment to Sustainability
      Commitment to Culture & Employees
      Charitable Giving
      We Remember
  • Strategies
    • Strategies Overview
      Asset Classes
      Vehicles
      Strategy Finder
      Large Cap
      Mid Cap
      Small/SMid Cap
      International
      Alternatives
      Specialty
      Focus
      Mutual Funds
      ETFs
      Interval Funds
      SMAs
      Institutional Separate Accounts
      UCITS
      Collective Investment Trusts
  • Insights
    • Insights
      Blogs
      Alger On the Money
      Alger On the Record
      Manager Commentary
      Capital Markets Outlook
      Retirement Solutions
      Viewpoints
      The Power of Focus
  • Newsroom
    Press ReleasesIn the News
  • Contact Us
AI, What Have You DoneFor Me Today?
.st0 { fill: #999999; } Explore Insights .st0 { fill: #999999; } Subscribe to Emails .st0 { fill: #999999; } .st0 { fill: #999999; } Download PDF

Healthcare: Minimally Invasive Surgery​

In our series: AI, What Have You Done for Me Today? we explore how such advancements in AI-enhanced healthcare are making surgeries safer and more efficient and benefiting both patients and healthcare providers.

​​​​​​

​While many investors are familiar with Artificial Intelligence (AI) through chatbots and virtual assistants, the impact of AI extends far beyond these familiar applications. In fact, AI has become an intrinsic part of our daily lives, often in ways not immediately visible to the public. Today, in industries such as agriculture, transportation, waste management, e-commerce, energy, and healthcare, AI is often behind the scenes, quietly revolutionizing business processes and enhancing operational efficiencies.​​ Detailed image showing a doctor with a tablet controlling an AI-enhanced robotic arm​
​

AI & Minimally Invasive Surgery

Imagine you'​ve just had a skiing accident and injured your knee. Your doctor recommends surgery and introduces the idea of being assisted by a sophisticated AI-enhanced robotic tool designed to improve precision and safe​​ty during the procedure. You might feel nervous about the idea of AI being involved in your surgery, but here's why it could be beneficial.

AI-enhanced robotic arms facilitate movements with greater precision than human hands, reducing even the slightest of tremors or shakes during surgical procedures and ensuring that every movement made is smooth and controlled. Further, AI-enhanced imaging offers high-definition 3D visualizations of the surgical area, delivering clearer and more detailed views than traditional methods. As a result, AI-enhanced technology can elevate less experienced surgeons to perform comparably to their more accomplished peers. ​

Such features can lead to several benefits for you as a patient:​

  • Smaller Incisions: Because robotic arms can make tiny, precise cuts, the incisions are smaller which usually means less pain and faster healing.
  • Lower Risk of Complications: The precision of the robotic system reduces the risk of complications during surgery.
  • ​ Faster Recovery: Smaller incisions and more precise surgery often mean a quicker recovery time.

Sample Holding

Intuitive Surgical’s (ISRG) AI-enhanced da Vinci system is a widely used robotic-assisted platform that combines the expertise of your surgeon with advanced technology to ensure best possible outcomes. So, while these tools might seem futuristic, they can help make your surgery safer and more effective.
​
​

Other Applications

​And AI is quietly revolutionizing the field of non-invasive surgery in other ways, including:

​
  • Preoperative Planning and Imaging AI can convert two-dimensional images into detailed three-dimensional models, allowing surgeons to visualize and rehearse procedures in a virtual environment before the actual surgery.
  • Real-Time Decision Support AI can provide real-time decision support during surgery, suggesting optimal surgical paths, highlighting vital areas and potential risks, and enabling surgeons to make informed decisions quickly.
  • ​ Postoperative Monitoring and Care AI extends its benefits to postoperative care by continuously monitoring patient data and predicting potential complications. This proactive approach not only improves patient outcomes but also reduces hospital stays and associated healthcare costs.
​​Such advancements in AI-enhanced healthcare are making surgeries safer and more efficient and benefiting both patients and healthcare providers.​



​
​

Recommended Insights for You:

​​
​The views expressed are the views of Fred Alger Management, LLC (“FAM”) and its affiliates as of June 2024. These views are subject to change at any time and may not represent the views of all portfolio management teams. These views should not be interpreted as a guarantee of the future performance of the markets, any security or any funds managed by FAM. These views are not meant to provide investment advice and should not be considered a recommendation to purchase or sell securities.
​
​​​Risk Disclosures:
Investing in the stock market involves risks, including the potential loss of principal. Growth stocks may be more volatile than other stocks as their prices tend to be higher in relation to their companies’ earnings and may be more sensitive to market, political, and economic developments. Local, regional or global events such as environmental or natural disasters, war, terrorism, pandemics, outbreaks of infectious diseases and similar public health threats, recessions, or other events could have a significant impact on investments. Investing in innovation is not without risk and there is no guarantee that investments in research and development will result in a company gaining market share or achieving enhanced revenue. Also, developing technologies to displace older technologies or create new markets may not in fact do so, and there may be sector specific risks as well. As is the case with any industry, there will be winners and losers that emerge, and investors therefore need to conduct a significant amount of due diligence on individual companies to assess these risks and opportunities. Companies involved in, or exposed to, AI-related businesses may have limited product lines, markets, financial resources, or personnel as they face intense competition and potentially rapid product obsolescence. These companies may be substantially exposed to the market and business risks of other industries or sectors and may be adversely affected by negative developments impacting those companies, industries, or sectors, as well as by loss or impairment of intellectual property rights or misappropriation of their technology. Companies that utilize AI could face reputational harm, competitive harm, and legal liability, and/or an adverse effect on business operations as content, analyses, or recommendations that AI applications produce may be deficient, inaccurate, biased, misleading or incomplete, may lead to errors, and may be used in negligent or criminal ways. Companies exploring new technologies may face regulatory, political or legal challenges that may adversely impact their competitive positioning and financial prospects.

Important Information for US ​Investors: This material must be accompanied by the most recent fund fact sheet(s) if used in connection with the sale of mutual fund and ETF shares. Fred Alger & Company, LLC serves as distributor of the Alger mutual funds.

Important Information for UK and EU Investors: This material is directed at investment professionals and qualified investors (as defined by MiFID/FCA regulations). It is for information purposes only and has been prepared and is made available for the benefit investors. This material does not constitute an offer or solicitation to any person in any jurisdiction in which it is not authorized or permitted, or to anyone who would be an unlawful recipient, and is only intended for use by original recipients and addressees. The original recipient is solely responsible for any actions in further distributing this material and should be satisfied in doing so that there is no breach of local legislation or regulation.

Certain products may be subject to restrictions with regard to certain persons or in certain countries under national regulations applicable to such persons or countries.

Alger Management, Ltd. (85 Gresham Street, Suite 308, London EC2V 7NQ, UK) is authorized and regulated by the Financial Conduct Authority, for the distribution of regulated financial products and services. FAM and/or Weatherbie Capital, LLC, U.S. registered investment advisors, serve as sub-portfolio manager to financial products distributed by Alger Management, Ltd.

Alger Group Holdings, LLC (parent company of FAM and Alger Management, Ltd.), FAM, and Fred Alger & Company, LLC are not authorized persons for the purposes of the Financial Services and Markets Act 2000 of the United Kingdom (“FSMA”) and this material has not been approved by an authorized person for the purposes of Section 21(2)(b) of the FSMA.

Important information for Investors in Israel: This material is provided in Israel only to investors of the type listed in the first schedule of the Securities Law, 1968 (the "Securities Law") and the Regulation of Investment Advice, Investment Marketing and Investment Portfolio Management Law, 1995. The Fund units will not be sold to investors who are not of the type listed in the first schedule of the Securities Law.

The following represents the noted percentages of firmwide assets under management as of March 31, 2024: Intuitive Surgical, Inc., 0.76%.

Fred Alger & Company, LLC 100 Pearl Street, New York, NY 10004 / 800.305.8547 / www.alger.com

RecommendedContent Title

ETF Investors

This ETF is different from traditional ETFs.

Traditional ETFs tell the public what assets they hold each day. This ETF will not. This may create additional risks for your investment. Specifically:

You may have to pay more money to trade the ETF’s shares. This ETF will provide less information to traders, who tend to charge more for trades when they have less information.

The price you pay to buy ETF shares on an exchange may not match the value of the ETF’s portfolio. The same is true when you sell shares. These price differences may be greater for this ETF compared to other ETFs because it provides less information to traders.

These additional risks may be even greater in bad or uncertain market conditions.

The differences between this ETF and other ETFs may also have advantages. By keeping certain information about the ETF confidential, this ETF may face less risk that other traders can predict or copy its investment strategy. This may improve the ETF’s performance. If other traders are able to copy or predict the ETF’s investment strategy, however, this may hurt the ETF’s performance. For additional information regarding the unique attributes and risks of this ETF, please refer to the prospectus.

ABOUT ALGER

  • Our History
  • Our Investment Approach
  • Investment Team
  • Careers
  • Charitable Giving
  • We Remember
  • Documents & Forms
  • Fund Literature
  • FAQs

ESG

  • Commitment to Sustainability
  • Alger's Approach to ESG Investing and Oversight
  • Weatherbie’s Approach to ESG Investing and Oversight
  • Redwood's Approach to Responsible Investing
  • Commitment to Culture & Employees

ASSET CLASSES

  • Large Cap
  • Mid Cap
  • Small/SMid Cap
  • International
  • Alternatives
  • Specialty
  • Focus

VEHICLES

  • Mutual Funds
  • ETFs
  • Interval Funds
  • SMAs
  • Institutional Separate Accounts
  • UCITS
  • Collective Investment Trusts

TOOLS

  • Strategy Finder
  • 10 Year Estimator
  • Quarterly Expense Estimator

INSIGHTS

  • Featured Insights
  • Capital Markets Outlook
  • Alger On the Money
  • Alger On the Record
  • The Alger Podcast
  • Search All Insights

NEWSROOM

  • Press Releases
  • In the News

LITERATURE

  • Mutual Funds
  • SMAs
  • Institutional Separate Accounts
  • UCITS

CONTACT US

  • All Inquiries

LEGAL NOTICES

  • Proxy Information
  • 2026 Estimated Dividends & Distribution Information
  • Sales Charges
  • Customer Relationship Summaries
  • UK Investor Report
  • Form ADVs
  • Interval Fund Repurchasing Schedule
View Mobile Site

Copyright Alger All Rights Reserved Privacy Policy Business Continuity Terms and Conditions
youtube channel LinkedIn Instagram